Searched for:
(1 - 6 of 6)
document
Schönbeck, Y. (author), Verkerk, P.H. (author)
report 2018
document
van der Ploeg, C.P.B. (author), Olthof, M.C. (author), Eekhout, I. (author), Schönbeck, Y. (author), Verkerk, P.H. (author)
report 2018
document
Dankert-Roelse, J. (author), Bouva, M. (author), de Winter-de Groot, Y. (author), Schönbeck, Y. (author), Gille, H. (author), Gulmans, V.A.M. (author), Verschoof-Puite, R. (author), Dompeling, E. (author), Schielen, P. (author), Verkerk, P. (author)
Workshop. Since May 1, 2011, newborn screening for Cystic Fibrosis (NBSCF) is part of the Dutch NBS program Objectives: To assess the validity of the four-step screening strategy when applied in a routine newborn screening program. Methods: NBSCF was carried out as a 4-step strategy (Immunotrypsinogen (IRT)/Pancreatitis-associated Protein (PAP)...
conference paper 2017
document
Schönbeck, Y. (author), Olthof, R. (author), van der Ploeg, K. (author), Verkerk, P.H. (author)
The Newborn Blood Spot screening program (NBS) was introduced in the Netherlands in 1974. The program is coordinated by the Centre for Population Screening (CvB) of the National Institute for Public health and the Environment (RIVM). The aim of the NBS is the early detection of certain serious congenital disorders in newborns. Children with...
report 2017
document
Schönbeck, Y. (author), Verkerk, P.H. (author)
report 2016
document
Schönbeck, Y. (author), Rijpstra, A. (author), Verkerk, P.H. (author)
report 2015
Searched for:
(1 - 6 of 6)